Relmada Therapeutics Inc XNAS: RLMD

Download real time

1.59 0.07 (4.61%)

60.05% Fall from 52W High

425.4K

XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Relmada Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents